Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 140Leukemia 132Lymphoma 90Leukemia, Myeloid, Acute 62Myelodysplastic Syndromes 47Burkitt Lymphoma 46Lymphoma, Non-Hodgkin 44Lymphoma, Large B-Cell, Diffuse 37Breast Neoplasms 37Lymphoma, Mantle-Cell 33Leukemia, Lymphocytic, Chronic, B-Cell 33Hodgkin Disease 32Multiple Myeloma 29Congenital Abnormalities 29Myeloproliferative Disorders 27Lymphoma, Follicular 27Leukemia, Myeloid, Accelerated Phase 27Graft vs Host Disease 27Leukemia, Myelomonocytic, Chronic 25Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Myeloid, Chronic-Phase 24Blast Crisis 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Anemia, Refractory, with Excess of Blasts 20Recurrence 18Primary Myelofibrosis 17Neoplasms, Plasma Cell 17Dendritic Cell Sarcoma, Interdigitating 17Osteosarcoma 16

Interventions

Carboplatin 27Paclitaxel 23Cisplatin 22Gemcitabine 17pembrolizumab 15Fluorouracil 9Pemetrexed 8Everolimus 8Docetaxel 8Cetuximab 8Radiotherapy, Intensity-Modulated 7Radiotherapy 7130-nm albumin-bound paclitaxel 7Sorafenib 6Nivolumab 6Bevacizumab 6Axitinib 6epothilone B 5Sunitinib 5Radiation 5Panitumumab 5Cyclophosphamide 5trebananib 4reolysin 4padeliporfin 4lenvatinib 4Irinotecan 4Gefitinib 4vosaroxin 3volociximab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma × Methotrexate × Clear all
NCT02412670 2023-07-10

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
36 enrolled 14 charts
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡